(Q44461789)

3 December 2017

title

Arylaminoethyl amides as inhibitors of the cysteine protease cathepsin K-investigating P1' substituents (English)

1 reference

3 December 2017

Eva Altmann

1

1 reference

3 December 2017

Jonathan Green

series ordinal

2

1 reference

3 December 2017

Marina Tintelnot-Blomley

series ordinal

3

1 reference

3 December 2017

language of work or name

English

0 references

publication date

1 June 2003

1 reference

Bioorganic & Medicinal Chemistry Letters

3 December 2017

published in

1 reference

3 December 2017

volume

13

1 reference

3 December 2017

issue

12

1 reference

3 December 2017

page(s)

1997-2001

1 reference

Protease inhibitors: current status and future prospects

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900344-5

7 January 2021

Novel, nonpeptidic cyanamides as potent and reversible inhibitors of human cathepsins K and L.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900344-5

7 January 2021

Cyclic ketone inhibitors of the cysteine protease cathepsin K.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900344-5

7 January 2021

Azepanone-based inhibitors of human and rat cathepsin K

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900344-5

7 January 2021

Identification of potent and selective mechanism-based inhibitors of the cysteine protease cruzain using solid-phase parallel synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900344-5

7 January 2021

Arylaminoethyl amides as novel non-covalent cathepsin K inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900344-5

7 January 2021

Molecular cloning of human cDNA for cathepsin K: novel cysteine proteinase predominantly expressed in bone

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900344-5

7 January 2021

Cathepsin K, but not cathepsins B, L, or S, is abundantly expressed in human osteoclasts

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900344-5

7 January 2021

The collagenolytic activity of cathepsin K is unique among mammalian proteinases

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900344-5

7 January 2021

Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900344-5

7 January 2021

Characterization of novel cathepsin K mutations in the pro and mature polypeptide regions causing pycnodysostosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900344-5

7 January 2021

QXP: powerful, rapid computer algorithms for structure-based drug design.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900344-5

7 January 2021

Human cathepsin O2, a novel cysteine protease highly expressed in osteoclastomas and ovary molecular cloning, sequencing and tissue distribution

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900344-5

7 January 2021

10.1016/S0960-894X(03)00344-5

Identifiers

DOI

1 reference

3 December 2017

1 reference